Toxoplasma gondii infection in patients with brain tumors in Southern Iran: a case-control study

[1]  M. Bahreini,et al.  Viability and infectivity of Toxoplasma gondii tachyzoites exposed to Butanedione monoxime , 2020, Journal of Parasitic Diseases.

[2]  P. Karanis,et al.  Seroepidemiology and Associated Risk Factors of Toxoplasma gondii in Hemodialysis Patients , 2020, Acta Parasitologica.

[3]  B. Clough,et al.  Human immunity to Toxoplasma gondii , 2019, PLoS pathogens.

[4]  Q. Asgari,et al.  Molecular genotyping and serological evaluation of Toxoplasma gondii in mothers and their spontaneous aborted fetuses in Southwest of Iran. , 2019, Comparative immunology, microbiology and infectious diseases.

[5]  M. Oliveira,et al.  Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion , 2018, Front. Immunol..

[6]  A. Elasbali,et al.  The relationship between toxoplasmosis and different types of human tumors. , 2018, Journal of infection in developing countries.

[7]  A. Koshy,et al.  Toxoplasma gondii: Entry, association, and physiological influence on the central nervous system , 2017, PLoS pathogens.

[8]  K. Cheeseman,et al.  Parasites et cancer : existe-t-il un lien ? , 2016 .

[9]  A. Rostami,et al.  The correlation between Toxoplasma gondii infection and prenatal depression in pregnant women , 2016, European Journal of Clinical Microbiology & Infectious Diseases.

[10]  J. Chai,et al.  High Toxoplasma gondii Seropositivity among Brain Tumor Patients in Korea , 2016, The Korean journal of parasitology.

[11]  A. Koshy,et al.  Neurons are the Primary Target Cell for the Brain-Tropic Intracellular Parasite Toxoplasma gondii , 2016, PLoS pathogens.

[12]  Guo-Hua Liu,et al.  Toxoplasma gondii infection in cancer patients: prevalence, risk factors, genotypes and association with clinical diagnosis. , 2015, Cancer letters.

[13]  A. Daryani,et al.  Toxoplasmosis in immunocompromised patients in Iran: a systematic review and meta-analysis. , 2014, Journal of infection in developing countries.

[14]  P. Brindley,et al.  Schistosome and liver fluke derived catechol-estrogens and helminth associated cancers , 2014, Front. Genet..

[15]  E. Weiderpass,et al.  Infection and cancer: global distribution and burden of diseases. , 2014, Annals of global health.

[16]  A. Daryani,et al.  Seroprevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis. , 2014, Acta tropica.

[17]  R. Shafiei,et al.  Seroprevalence and molecular diagnosis of Toxoplasma gondii infection among blood donors in southern Iran. , 2014, Journal of infection in developing countries.

[18]  F. Roperto,et al.  Bovine papillomavirus E5 and E7 oncoproteins in naturally occurring tumors: are two better than one? , 2013, Infectious Agents and Cancer.

[19]  D. Missé,et al.  Brain cancer mortality rates increase with Toxoplasma gondii seroprevalence in France. , 2012, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[20]  D. Missé,et al.  Incidence of adult brain cancers is higher in countries where the protozoan parasite Toxoplasma gondii is common , 2012, Biology Letters.

[21]  J. Flegr,et al.  The Distribution of Toxoplasma gondii Cysts in the Brain of a Mouse with Latent Toxoplasmosis: Implications for the Behavioral Manipulation Hypothesis , 2011, PloS one.

[22]  J. Al-Alami,et al.  Reactivation of latent Toxoplasma gondii in immunocompromised cancer patients , 2011, Comparative Clinical Pathology.

[23]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[24]  J. M. Thomson,et al.  Toxoplasma gondii Infection Specifically Increases the Levels of Key Host MicroRNAs , 2010, PloS one.

[25]  H. Ng,et al.  Oncogenic role of microRNAs in brain tumors , 2009, Acta Neuropathologica.

[26]  J. Laliberté,et al.  Host cell manipulation by the human pathogen Toxoplasma gondii , 2008, Cellular and Molecular Life Sciences.

[27]  B. Liu,et al.  Toxoplasma gondii antibodies in cancer patients. , 2007, Cancer letters.

[28]  J. Dubey,et al.  Human indoleamine 2,3-dioxygenase inhibits Toxoplasma gondii growth in fibroblast cells. , 1994, Journal of interferon research.

[29]  J. McNeil,et al.  Tumours of the brain and presence of antibodies to Toxoplasma gondii. , 1993, International journal of epidemiology.